Royan Ajay
Insider CIK 1875614 · GUTS Director, 10% owner · ADGI Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GUTS FRACTYL HEALTH, INC. | P Buy | 2026-06-12 | 2026-06-15 | 23,000 | $0.85 | $19.6K | 40,901 | SEC↗ |
| GUTS FRACTYL HEALTH, INC. | A Award deriv | 2026-06-10 | 2026-06-11 | 22,500 | — | $0 | 22,500 | SEC↗ |
| IVVD Invivyd, Inc. | A Award deriv | 2026-05-19 | 2026-05-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GUTS FRACTYL HEALTH, INC. | A Award deriv | 2025-06-11 | 2025-06-13 | 22,500 | — | $0 | 22,500 | SEC↗ |
| IVVD Invivyd, Inc. | A Award deriv | 2025-05-20 | 2025-05-22 | 8,219 | — | $0 | 8,219 | SEC↗ |
| IVVD Invivyd, Inc. | A Award deriv | 2025-03-24 | 2025-03-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GUTS FRACTYL HEALTH, INC. | P Buy | 2025-03-14 | 2025-03-18 | 17,901 | $1.28 | $22.9K | 17,901 | SEC↗ |
| GUTS Fractyl Health, Inc. | C Conversion deriv | 2024-02-06 | 2024-02-08 | 6,502,796 | — | $0 | 0 | SEC↗ |
| GUTS Fractyl Health, Inc. | C Conversion deriv | 2024-02-06 | 2024-02-08 | 4,025,764 | — | $0 | 0 | SEC↗ |
| GUTS Fractyl Health, Inc. | C Conversion deriv | 2024-02-06 | 2024-02-08 | 545,450 | — | $0 | 0 | SEC↗ |
| GUTS Fractyl Health, Inc. | C Conversion deriv | 2024-02-06 | 2024-02-08 | 373,021 | — | $0 | 0 | SEC↗ |
| GUTS Fractyl Health, Inc. | C Conversion deriv | 2024-02-06 | 2024-02-08 | 1,598,225 | — | $0 | 0 | SEC↗ |
| GUTS Fractyl Health, Inc. | C Conversion | 2024-02-06 | 2024-02-08 | 5,160,301 | — | $0 | 5,160,301 | SEC↗ |
| GUTS Fractyl Health, Inc. | C Conversion | 2024-02-06 | 2024-02-08 | 918,567 | — | $0 | 918,567 | SEC↗ |
| GUTS Fractyl Health, Inc. | P Buy | 2024-02-06 | 2024-02-08 | 333,333 | $15.00 | $5.00M | 1,251,900 | SEC↗ |
| GUTS Fractyl Health, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ADGI Adagio Therapeutics, Inc. | C Conversion deriv | 2021-08-10 | 2021-08-12 | 1,250,000 | — | $0 | 0 | SEC↗ |
| ADGI Adagio Therapeutics, Inc. | C Conversion deriv | 2021-08-10 | 2021-08-12 | 422,612 | — | $0 | 0 | SEC↗ |
| ADGI Adagio Therapeutics, Inc. | C Conversion deriv | 2021-08-10 | 2021-08-12 | 176,304 | — | $0 | 0 | SEC↗ |
| ADGI Adagio Therapeutics, Inc. | P Buy | 2021-08-10 | 2021-08-12 | 1,997,000 | $17.00 | $33.95M | 11,241,580 | SEC↗ |
| ADGI Adagio Therapeutics, Inc. | C Conversion | 2021-08-10 | 2021-08-12 | 9,244,580 | — | $0 | 9,244,580 | SEC↗ |
| ADGI Adagio Therapeutics, Inc. | A Award deriv | 2021-08-05 | 2021-08-09 | 35,593 | — | $0 | 35,593 | SEC↗ |